EWTX insider buying – Edgewise Therapeutics, Inc.
10 insider purchases since 2016 worth $42.3M by 8 different insiders. Last 12 months: 1 purchases, $199,448. Most recent filing: 2025-11-13.
Mid company Public float $1.2B (latest 10-K, SEC).
Same time range as the chart above - each mark sits under the week of the trade. Circles = purchases (height = price paid, size = amount), red triangles = open-market sales of $50k+. Prices as reported, not adjusted for later stock splits. 3 older purchases (before the 5-year window) are listed in the table below.
Purchases are open-market buys (SEC Form 4, code "P") - insiders paying with their own money. Sales are open-market sales (code "S") of $50,000 or more; many sales are pre-planned (Rule 10b5-1) or made for taxes and diversification. Each row links to the original filing.
Bought, sold, still holding?
| Insider | Bought | First / last buy | Sold since 2016 | Holds now* | Status |
|---|---|---|---|---|---|
| OrbiMed Genesis GP LLC Director | $15.0M 2× · 981,267 sh | 2022-09-16 2025-04-03 | – | 14,809,075 shares as of 2025-04-04 | Holds - never sold |
| Deerfield Private Design Fund IV, L.P. 10% Owner | $10.0M 1× · 625,000 sh | 2021-03-30 2021-03-30 | – | 3,933,137 shares as of 2021-03-30 | Holds - never sold |
| ORBIMED ADVISORS LLC Director | $5.8M 1× · 359,375 sh | 2021-03-30 2021-03-30 | – | 319,599 shares as of 2021-03-31 | Holds - never sold |
| Novo Holdings A/S 10% Owner | $5.0M 1× · 484,496 sh | 2022-09-14 2022-09-14 | – | 6,071,703 shares as of 2022-09-16 | Holds - never sold |
| OrbiMed Capital GP VI LLC Director | $5.0M 1× · 454,545 sh | 2024-01-23 2024-01-23 | – | 14,436,497 shares as of 2024-01-25 | Holds - never sold |
| Thompson Peter A. Director | $994,980 1× · 138,000 sh | 2022-05-18 2022-05-18 | – | 443,792 shares as of 2025-04-04 | Holds - never sold |
| Fox Jonathan C Director | $300,418 2× · 21,557 sh | 2023-12-26 2025-11-11 | – | 24,833 shares as of 2026-07-01 | Holds - never sold |
| ROOT JONATHAN D Director | $250,000 1× · 15,625 sh | 2021-03-30 2021-03-30 | – | 15,625 shares as of 2022-02-28 | Holds - never sold |
* Shares held after the insider's most recent SEC filing for this company (all share classes, direct and indirect). If an insider stops filing, later changes are not known.
Insider buying and selling by year
| Year | Purchases | Bought | Buyers | Sales | Sold |
|---|---|---|---|---|---|
| 2026 | 0 | – | – | 11 | $17.4M |
| 2025 | 2 | $10.2M | 2 | 9 | $5.4M |
| 2024 | 1 | $5.0M | 1 | 12 | $15.1M |
| 2023 | 1 | $100,970 | 1 | 2 | $1.7M |
| 2022 | 3 | $11.0M | 3 | 8 | $1.4M |
| 2021 | 3 | $16.0M | 3 | 8 | $4.9M |
Insider purchases
| Filed | Insider | Role | Shares | Avg price | Value | Holdings | Filing |
|---|---|---|---|---|---|---|---|
| 2025-11-13 | Fox Jonathan C | Director | 10,700 | $18.64 | $199,448 | +82.3% | SEC |
| 2025-04-04 | OrbiMed Genesis GP LLC | Director | 496,771 | $20.13 | $10.0M | +3.5% | SEC |
| 2024-01-25 | OrbiMed Capital GP VI LLC | Director | 454,545 | $11.00 | $5.0M | +3.3% | SEC |
| 2023-12-28 | Fox Jonathan C | Director | 10,857 | $9.30 | $100,970 | SEC | |
| 2022-09-16 | OrbiMed Genesis GP LLC | Director | 484,496 | $10.32 | $5.0M | +3.6% | SEC |
| 2022-09-16 | Novo Holdings A/S | 10% Owner | 484,496 | $10.32 | $5.0M | +8.7% | SEC |
| 2022-05-20 | Thompson Peter A. | Director | 138,000 | $7.21 | $994,980 | +1.0% | SEC |
| 2021-03-31 | ROOT JONATHAN D | Director | 15,625 | $16.00 | $250,000 | SEC | |
| 2021-03-31 | ORBIMED ADVISORS LLC | Director | 359,375 | $16.00 | $5.8M | +2.8% | SEC |
| 2021-03-30 | Deerfield Private Design Fund IV, L.P. | 10% Owner | 625,000 | $16.00 | $10.0M | +18.9% | SEC |
Insider sales
| Filed | Insider | Role | Shares | Avg price | Value | Type | Filing |
|---|---|---|---|---|---|---|---|
| 2026-08-14 | Russell Alan J | Officer | 5,901 | $43.73 | $258,060 | Sale | SEC |
| 2026-08-14 | MOORE JOHN R | Officer | 5,016 | $43.83 | $219,830 | Sale | SEC |
| 2026-08-14 | KOCH KEVIN | CEO | 17,971 | $43.68 | $785,050 | Sale | SEC |
| 2026-08-14 | Donovan Joanne M. | Officer | 9,441 | $43.71 | $412,712 | Sale | SEC |
| 2026-08-14 | Derakhshan Behrad | Officer | 5,100 | $43.81 | $223,420 | Sale | SEC |
| 2026-07-02 | Russell Alan J | Officer | 200,000 | $39.41 | $7.9M | Sale | SEC |
| 2026-05-05 | Donovan Joanne M. | Officer | 55,230 | $37.88 | $2.1M | Sale | SEC |
| 2026-04-02 | Donovan Joanne M. | Officer | 28,662 | $32.31 | $926,069 | Sale | SEC |
| 2026-03-31 | Donovan Joanne M. | Officer | 21,338 | $32.12 | $685,377 | Sale | SEC |
| 2026-03-30 | Donovan Joanne M. | Officer | 16,358 | $30.98 | $506,771 | Sale | SEC |
| 2026-01-23 | Edris Badreddin | Director | 115,471 | $29.44 | $3.4M | Sale | SEC |
| 2025-11-13 | Russell Alan J | Officer | 100,000 | $21.12 | $2.1M | Sale | SEC |
| 2025-08-28 | Russell Alan J | Officer | 100,000 | $14.60 | $1.5M | Sale | SEC |
| 2025-08-14 | KOCH KEVIN | CEO | 7,972 | $13.39 | $106,745 | Sale | SEC |
| 2025-05-07 | KOCH KEVIN | CEO | 4,276 | $16.45 | $70,340 | Sale | SEC |
Showing the latest 15 of 50 sales of $50,000+ since 2016.
Compiled automatically from public SEC filings. Not investment advice. Get every new insider purchase in the daily report.
Get every new insider purchase the day it's filed
Daily report with all SEC insider buys, cluster buys, company events and the crypto money-flow radar.
Get started free